Emerging delivery systems to reduce doxorubicin cardiotoxicity and improve therapeutic index: focus on liposomes
Year: 2014
Type: review
Source: Anti-Cancer Drugs
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Janssen Pharmaceuticals
OpenAlex ID: W2331664759
